 of the
cohort received treatment for GSV.
SSV outcomes. When RFA was compared with CAC,
there were no signiÔ¨Åcant differences for outcomes such
as anatomic closure at 1 month (RR, 0.99; 95% CI, 0.881.12; phlebitis, RR, 3.60; 95% CI, 0.16-82.05;